OPTH (Optimi Health Corp.) — Research Summary as of August 5, 2026

Company Overview

Optimi Health Corp. (NASDAQ: OPTH / CSE: OPTI / FSE: 8BN) is a Canadian company focused on pharmaceutical-grade psychedelic compounds, including naturally derived psilocybin and ibogaine. The company operates GMP-certified production facilities in Canada and is positioning itself within the growing regulatory and clinical landscape for psychedelic-assisted therapies for mental health [1][20].

---

Key Recent Catalysts (Last ~1–3 Months)